Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PMCB
PMCB logo

PMCB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy PharmaCyte Biotech Inc (PMCB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.710
1 Day change
-2.60%
52 Week Range
1.510
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

PMCB is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is weak technically, has no recent news catalyst, no bullish proprietary signal, and the options activity does not show meaningful buying pressure. Based on the data provided, the direct call is to avoid buying now.

Technical Analysis

PMCB is in a bearish trend. The MACD histogram is negative and still expanding lower, showing downside momentum. RSI_6 at 37.125 is neutral-to-weak, not indicating a strong rebound. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend structure. Price at 0.715 is below the pivot at 0.755 and only slightly above S1 at 0.722, with nearby support at S2 0.702. The short-term pattern data suggests only modest upside probabilities, but not enough to override the broader bearish setup.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is not supportive. Put-call ratios are 0.0 because there is essentially no meaningful options activity today, with option volume at 0 and only minimal open interest. Implied volatility is extremely high at 997.18, with IV rank 99.69 and IV percentile 98.81, showing elevated uncertainty rather than clear bullish positioning. This is not a strong signal of smart-money accumulation.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
3

Positive Catalysts

  • No recent news in the last week. No AI Stock Picker signal. No SwingMax signal. No recent congress trading activity. Short-term pattern data suggests a modest probability of a small rebound over the next week and month, but this is weak as a catalyst.

Neutral/Negative Catalysts

  • No recent news-driven catalyst, no bullish proprietary trading signal, and no significant hedge fund or insider buying trend. Technicals remain bearish, with MACD negative and moving averages stacked bearishly. Options data shows no meaningful activity to support accumulation. The stock also lacks valuation and financial snapshot support in the provided data.

Financial Performance

Latest quarter financials could not be assessed because the financial snapshot returned an error. The latest quarter season is not available in the provided data, so there is no confirmable revenue or growth trend to support a long-term buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no visible Wall Street upgrade/downgrade or target direction to support a bullish view. Overall, the pros view is limited by missing fundamentals, while the cons view is stronger due to weak technicals and lack of catalysts.

Wall Street analysts forecast PMCB stock price to rise
Analyst Rating
0
Wall Street analysts forecast PMCB stock price to rise
Buy
Hold
Sell
0
Current: 0.730
sliders
Low
0
Averages
0
High
0
0
Current: 0.730
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch